Overview

Probiotic in Dry Eye Syndromes

Status:
Not yet recruiting

Trial end date:
2021-10-30

Target enrollment:

Participant gender:

Summary

This study will evaluate efficacy and safety of systemic and ophthalmic probiotic from bacterial lysate of Lactobacillus sakei on microbiota, immunological and clinical outcomes of patients with Dry Eye Syndrome.

Phase:

Phase 2

Details

Lead Sponsor:

Shiraz University of Medical Sciences